Search

Search Constraints

You searched for: Author/Creator Santana, Hector

Search Results

1. Formulation matters! A spectroscopic and molecular dynamics investigation on the peptide CIGB552 as itself and in its therapeutical formulation. (10th June 2021)

2. A first‐in‐class, first‐in‐human, phase I trial of CIGB‐552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF‐κB in patients with advanced solid tumors. Issue 6 (27th May 2021)

3. Recombinant Human Epidermal Growth Factor/Quatsome Nanoconjugates: A Robust Topical Delivery System for Complex Wound Healing. Issue 6 (12th March 2021)

4. The first report of cases of pet dogs with naturally occurring cancer treated with the antitumor peptide CIGB-552. (October 2017)

5. Recombinant Human Epidermal Growth Factor/Quatsome Nanoconjugates: A Robust Topical Delivery System for Complex Wound Healing (Adv. Therap. 6/2021). Issue 6 (14th June 2021)